Steve Pakola

747 total citations
20 papers, 528 citations indexed

About

Steve Pakola is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Molecular Biology. According to data from OpenAlex, Steve Pakola has authored 20 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Ophthalmology and 4 papers in Molecular Biology. Recurrent topics in Steve Pakola's work include Retinal and Macular Surgery (5 papers), Retinal Diseases and Treatments (4 papers) and Intraocular Surgery and Lenses (4 papers). Steve Pakola is often cited by papers focused on Retinal and Macular Surgery (5 papers), Retinal Diseases and Treatments (4 papers) and Intraocular Surgery and Lenses (4 papers). Steve Pakola collaborates with scholars based in Belgium, Denmark and United States. Steve Pakola's co-authors include Peter Stalmans, Marc D. de Smet, Christophe Delaey, Arnd Gandorfer, Anselm Kampik, Eric J. Feron, Marc Veckeneer, Donghuan Song, Jiandong Wei and Justin A. Zivin and has published in prestigious journals such as Blood, Neurology and Stroke.

In The Last Decade

Steve Pakola

20 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Pakola Belgium 11 285 271 145 126 73 20 528
Sidath E. Liyanage United Kingdom 15 350 1.2× 155 0.6× 44 0.3× 164 1.3× 57 0.8× 38 553
Katsunori Shimada Japan 14 395 1.4× 214 0.8× 58 0.4× 65 0.5× 27 0.4× 37 537
Woohyok Chang South Korea 13 487 1.7× 337 1.2× 49 0.3× 145 1.2× 15 0.2× 25 600
Christina Stathopoulos Switzerland 9 377 1.3× 131 0.5× 26 0.2× 107 0.8× 41 0.6× 29 529
Valérie Krivosic France 14 526 1.8× 343 1.3× 69 0.5× 99 0.8× 33 0.5× 31 632
Gordon Byrnes United States 8 386 1.4× 166 0.6× 69 0.5× 170 1.3× 26 0.4× 12 535
Mathieu F. Bakhoum United States 12 271 1.0× 170 0.6× 131 0.9× 143 1.1× 42 0.6× 34 499
Kanish Mirchia United States 12 80 0.3× 127 0.5× 74 0.5× 120 1.0× 56 0.8× 46 483
Markus S. Ladewig Germany 11 179 0.6× 107 0.4× 28 0.2× 170 1.3× 25 0.3× 19 547
J.M. Seddon United States 9 859 3.0× 459 1.7× 37 0.3× 328 2.6× 103 1.4× 14 1.0k

Countries citing papers authored by Steve Pakola

Since Specialization
Citations

This map shows the geographic impact of Steve Pakola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Pakola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Pakola more than expected).

Fields of papers citing papers by Steve Pakola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Pakola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Pakola. The network helps show where Steve Pakola may publish in the future.

Co-authorship network of co-authors of Steve Pakola

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Pakola. A scholar is included among the top collaborators of Steve Pakola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Pakola. Steve Pakola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veerapandiyan, Aravindhan, Vamshi K. Rao, Jahannaz Dastgir, et al.. (2024). RGX-202, an Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy: Interim Clinical Data (S21.005). Neurology. 102(7_supplement_1). 1 indexed citations
2.
Li, Guorong, Astrid F. Nottebaum, Mitchell Brigell, et al.. (2020). A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure. Investigative Ophthalmology & Visual Science. 61(14). 12–12. 36 indexed citations
3.
Sall, Kenneth, James H. Peace, Douglas G. Day, et al.. (2014). Initial Clinical Evaluation of Safety, Tolerability and Pharmacodynamics of the Locally-Acting ROCK Inhibitor AMA0076. 55(13). 565–565. 5 indexed citations
4.
Lassen, Ulrik, Dorte Nielsen, Morten Mau‐Sørensen, et al.. (2012). A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours. British Journal of Cancer. 106(4). 678–684. 37 indexed citations
5.
Verhamme, Peter, Sam Heye, Kathelijne Peerlinck, et al.. (2012). Catheter-directed thrombolysis with microplasmin for acute peripheral arterial occlusion (PAO): an exploratory study.. PubMed. 31(3). 289–96. 6 indexed citations
6.
Girach, Aniz & Steve Pakola. (2012). Vitreomacular interface diseases: pathophysiology, diagnosis and future treatment options. Expert Review of Ophthalmology. 7(4). 311–323. 17 indexed citations
7.
Folgar, Francisco A., Cynthia A. Toth, Francis Char DeCroos, et al.. (2012). Assessment of Retinal Morphology with Spectral and Time Domain OCT in the Phase III Trials of Enzymatic Vitreolysis. Investigative Ophthalmology & Visual Science. 53(11). 7395–7395. 15 indexed citations
8.
9.
Stalmans, Peter, et al.. (2010). INTRAVITREAL INJECTION OF MICROPLASMIN FOR TREATMENT OF VITREOMACULAR ADHESION. Retina. 30(7). 1122–1127. 77 indexed citations
10.
Verhamme, Peter, Steve Pakola, Thomas Jensen, et al.. (2010). Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clinical Therapeutics. 32(6). 1205–1220. 21 indexed citations
11.
12.
Smet, Marc D. de, Arnd Gandorfer, Peter Stalmans, et al.. (2009). Microplasmin Intravitreal Administration in Patients with Vitreomacular Traction Scheduled for Vitrectomy. Ophthalmology. 116(7). 1349–1355.e2. 96 indexed citations
13.
Verhamme, Peter, Steve Pakola, S Glazer, et al.. (2009). Thrombogram analysis of the long-acting anticoagulant effect of TB-402, a human anti-FVIII antibody, and of its interactions with rHVFIII, LMWH and Warfarin in healthy volunteers. 2 indexed citations
14.
Riisbro, Rikke, Lena Winstedt, Steve Pakola, et al.. (2009). Abstract A3: A first-in-man, phase I, dose escalation study of TB-403, a monoclonal antibody directed against PlGF, in healthy male subjects. Molecular Cancer Therapeutics. 8(12_Supplement). A3–A3. 1 indexed citations
15.
Lassen, Ulrik, Dorte Nielsen, Morten Mau‐Sørensen, et al.. (2009). Abstract A111: A phase I, dose escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with solid tumors. Molecular Cancer Therapeutics. 8(12_Supplement). A111–A111. 3 indexed citations
16.
Rasmussen, Rune Skovgaard, Karsten Overgaard, Steve Pakola, & Gudrun Boysen. (2008). Effects of microplasmin on recovery in a rat embolic stroke model. Neurological Research. 30(1). 75–81. 8 indexed citations
17.
Verhamme, Peter, Steve Pakola, Marc Jacquemin, et al.. (2007). Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.. Blood. 110(11). 312–312. 1 indexed citations
18.
Tanaka, Minoru, et al.. (2005). Safety of In Vivo Pharmacologic Vitreolysis with Recombinant Microplasmin in Rabbit Eyes. Investigative Ophthalmology & Visual Science. 46(9). 3295–3295. 51 indexed citations
19.
Armstrong, Paul W., Jeff Burton, Steve Pakola, et al.. (2003). Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II). American Heart Journal. 146(3). 484–488. 28 indexed citations
20.
Lapchak, Paul A., Dalia M. Araujo, Steve Pakola, et al.. (2002). Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits. Stroke. 33(9). 2279–2284. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sidath E. Liyanage Breakdown of academic impact, for papers by Katsunori Shimada Breakdown of academic impact, for papers by Woohyok Chang Breakdown of academic impact, for papers by Christina Stathopoulos Breakdown of academic impact, for papers by Valérie Krivosic Breakdown of academic impact, for papers by Gordon Byrnes Breakdown of academic impact, for papers by Mathieu F. Bakhoum Breakdown of academic impact, for papers by Kanish Mirchia Breakdown of academic impact, for papers by Markus S. Ladewig Breakdown of academic impact, for papers by J.M. Seddon
Rankless by CCL
2026